Structure defining of ultrapotent neutralizing nanobodies against MERS-CoV with novel epitopes on receptor binding domain
PLOS Pathogens · 14.08.2024 · 20 (8) · e1012438
DOI: 10.1371/journal.ppat.1012438 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 14.08.2024. Verfasst von Sen Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Frontiers Science Center for Synthetic Biology (Ministry of Education), Tianjin Key Laboratory of Function and Application of Biological Macromolecul…. Hauptthemen laut MEDLINE: Middle East Respiratory Syndrome Coronavirus, Single-Domain Antibodies, Epitopes, Antibodies, Neutralizing. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) causes severe and fatal acute respiratory disease in humans. High fatality rates and continued infectiousness remain a pressing concern for global health preparedness. Antibodies targeted at the receptor-binding domain (RBD) are major countermeasures against human viral infection. Here, we report four potent nanobodies against MERS-CoV, which are isolated from alpaca, and especially the potency of Nb14 is highest in the pseudotyped virus assay. Structural studies show that Nb14 framework regions (FRs) are mainly involved in interactions targeting a novel epitope, which is entirely distinct from all previously reported antibodies, and disrupt the protein-carbohydrate interaction between residue W535 of RBD and hDPP4 N229-linked carbohydrate moiety (hDPP4-N229-glycan). Different from Nb14, Nb9 targets the cryptic face of RBD, which is distinctive from the hDPP4 binding site and the Nb14 epitope, and it induces the β5-β6 loop to inflect towards a shallow groove of the RBD and dampens the accommodation of a short helix of hDPP4. The particularly striking epitopes endow the two Nbs administrate synergistically in the pseudotyped MERS-CoV assays. These results not only character unprecedented epitopes for antibody recognition but also provide promising agents for prophylaxis and therapy of MERS-CoV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Frontiers Science Center for Synthetic Biology (Ministry of Education), Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, School of Life Sciences, Tianjin University, Tianjin, P…
- Center for Public Health Research, Medical School, Nanjing University, Nanjing, P.R. China.
ORCID-Profile: Yaxin Wang
Förderung
- Ministry of Science and Technology
- National Natural Science Foundation of China
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Ma, S., Zhang, D., Wang, Q., Zhu, L., Wu, X., Ye, S., & Wang, Y. (2024). Structure defining of ultrapotent neutralizing nanobodies against MERS-CoV with novel epitopes on receptor binding domain. PLOS Pathogens, 20(8), e1012438. https://doi.org/10.1371/journal.ppat.1012438
Vancouver
Ma S, Zhang D, Wang Q, Zhu L, Wu X, Ye S, et al. Structure defining of ultrapotent neutralizing nanobodies against MERS-CoV with novel epitopes on receptor binding domain. PLOS Pathogens. 2024;20(8):e1012438. doi:10.1371/journal.ppat.1012438
BibTeX
@article{Ma2024,
author = {Ma, Sen and Zhang, Doudou and Wang, Qiwei and Zhu, Linjing and Wu, Xilin and Ye, Sheng and Wang, Yaxin},
title = {Structure defining of ultrapotent neutralizing nanobodies against MERS-CoV with novel epitopes on receptor binding domain},
journal = {PLOS Pathogens},
year = {2024},
volume = {20},
number = {8},
pages = {e1012438},
doi = {10.1371/journal.ppat.1012438}
}
EUVIMED